Abstract 1784: Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with <i>EGFR</i> mutations

Publisher Website

Abstract

This research paper explore the methodology and findings associated with Cancer Research. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now